Yes, they were almost terminal I feel. We have a much earlier group, I’m expecting even better results here, because at some point the metastasis is too far spread to so many different sites, that stopping it spread further would not help.

TNBC leronlimab

Quote:

---

Study population will consist of patients with CCR5-positive, locally advanced or metastatic triple-negative breast cancer (mTNBC) who are naïve to chemotherapy in metastatic setting but have been exposed to anthracyclines and taxane in neoadjuvant and adjuvant settings (first-line).

---

inclusion Criteria

Quote:

---

Subjects must be untreated or naïve to chemotherapy and/or checkpoint inhibitors exposure in metastatic setting and have been exposed to anthracyclines and taxane in neoadjuvant and adjuvant settings (first-line); Note: Patients who have been exposed to carboplatin in neoadjuvant or adjuvant setting will be allowed to enroll, if they have progressed ≥ 6 months from completion of treatment.

---

Quote:

---

Life expectancy of at least 6 months;

---